Therapy News and Research

RSS

Canadian study documents continued decline in hormone therapy usage

Ever since menopause was first discussed publicly, the debate over the use of hormone therapy (HT) has monopolized headlines.

22 Aug 2017

Study provides insights into how social touch affects people with ASD

People with strong signs of autism spectrum disorder (ASD) show neural signs of anxiety when they see social touch and report unpleasant feelings about social touch by comparison to people with weak signs of ASD.

22 Aug 2017

Kessler Foundation receives Wallerstein Foundation grant to advance stroke rehabilitation research

Kessler Foundation was awarded a $250,000 grant by the Wallerstein Foundation for Geriatric Life Improvement.

22 Aug 2017

Genes that regulate oxytocin linked to sociality of young individuals

A group of researchers from the National University of Singapore has found that CD38 and CD157 genes that regulate oxytocin, the supreme human social hormone, are associated with the sociality of young individuals.

22 Aug 2017

Female patients with esophageal cancer have superior response to treatment, study reveals

Female patients with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to the treatment than male patients are, and women are less likely to experience cancer recurrence, according to a study published online today in The Annals of Thoracic Surgery.

22 Aug 2017

Johns Hopkins researchers pinpoint how tiny protein could make deadly Ebola virus contagious

Two Johns Hopkins materials science graduate students and their professors played a key role in a multi-institution research project that pinpointed how a tiny protein seems to make the deadly Ebola virus particularly contagious.

22 Aug 2017

Researchers explore ways for computers to help improve patient care

Doctors are often deluged by signals from charts, test results, and other metrics to keep track of. It can be difficult to integrate and monitor all of these data for multiple patients while making real-time treatment decisions, especially when data is documented inconsistently across hospitals.

21 Aug 2017

Type 2 diabetes patients on MDI insulin therapy can benefit from CGM use, study shows

DexCom, Inc., announced today the publication of a new study that shows people with Type 2 diabetes on a multiple daily injection (MDI) insulin therapy benefit from the use of continuous glucose monitoring (CGM).

21 Aug 2017

Women with a medical history of breast or ovarian cancer often fail to test for inherited genetic changes

A new study conducted by the UCLA Fielding School of Public Health, states that among nearly 4 million women in the United States who possess a medical history of ovarian cancer or breast cancer, 1.5 million have an increased risk of bearing some kinds of genetic mutations, which might increase the probability of causing additional cancers in the future.

21 Aug 2017

Study: More than 80% of women at risk for breast, ovarian cancer have not taken simple genetic test

Of the nearly 4 million women in the United States who have had either breast cancer or ovarian cancer, at least 1.5 million have a high risk of carrying certain types of genetic mutations that could increase their risk for additional cancers in the future.

21 Aug 2017

Licorice could pose health risk by interacting with medications

Licorice roots have a diverse and flavorful history, having been used in ancient Egyptian times as a tea and in traditional Chinese medicines, all the way to today as a flavoring agent and as an ingredient in some licorice candies.

21 Aug 2017

Combination treatment effectively vaccinates mice against cancer

By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice.

18 Aug 2017

Too few patients follow the adage: You better shop around

Despite having more financial "skin in the game" than ever, many consumers don't make any attempt to compare prices for health care services, a newly released study found.

18 Aug 2017

Research identifies new gene fusions and mutations linked to GIST tumors

Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene

18 Aug 2017

Study provides evidence that oral immunotherapy may be possible cure for peanut allergy

Allergy immunotherapy company Prota Therapeutics Pty Ltd is pleased to announce results from a follow up study of the probiotic and peanut immunotherapy (PPOIT) treatment which it has licensed from the Murdoch Childrens Research Institute, demonstrating long-lasting tolerance effects of treatment more than four years after the original study ended.

18 Aug 2017

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) today approved Besponsa (inotuzumab ozogamicin) in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) - a rare form of ALL.

17 Aug 2017

Peanut allergy successfully kept at bay with immune-based therapy

Australian researchers from the Murdoch Children’s Research Institute have come up with a latest study results showing that peanut allergy could be treated successfully with an immune-based therapy. This new therapy helped children allergic to peanuts eat these nuts with no reactions for up to four years. The study appeared this week in the journal Lancet Child & Adolescent Health.

17 Aug 2017

Researchers get closer to creating new blood test that can identify breast cancer brain metastasis

Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response to therapy in real time.

17 Aug 2017

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

Women’s decision-making habits combined with values impact choice of breast cancer treatment

A new study finds that more than half of women with early stage breast cancer considered an aggressive type of surgery to remove both breasts.

17 Aug 2017

Therapy News and Research

Canadian study documents continued decline in hormone therapy usage

Study provides insights into how social touch affects people with ASD

Kessler Foundation receives Wallerstein Foundation grant to advance stroke rehabilitation research

Genes that regulate oxytocin linked to sociality of young individuals

Female patients with esophageal cancer have superior response to treatment, study reveals

Johns Hopkins researchers pinpoint how tiny protein could make deadly Ebola virus contagious

Researchers explore ways for computers to help improve patient care

Type 2 diabetes patients on MDI insulin therapy can benefit from CGM use, study shows

Women with a medical history of breast or ovarian cancer often fail to test for inherited genetic changes

Study: More than 80% of women at risk for breast, ovarian cancer have not taken simple genetic test

Licorice could pose health risk by interacting with medications

Combination treatment effectively vaccinates mice against cancer

Too few patients follow the adage: You better shop around

Research identifies new gene fusions and mutations linked to GIST tumors

Study provides evidence that oral immunotherapy may be possible cure for peanut allergy

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

Peanut allergy successfully kept at bay with immune-based therapy

Researchers get closer to creating new blood test that can identify breast cancer brain metastasis

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Women’s decision-making habits combined with values impact choice of breast cancer treatment

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News